CSIMarket


Strongbridge Biopharma plc  (SBBP)
Other Ticker:  
 


 

Strongbridge Biopharma plc

SBBP's Financial Statements and Analysis



Strongbridge Biopharma plc narrowed second quarter of 2021 net loss per share of $-0.21 compare to net loss per share of $-0.32 recorded in the same quarter a year ago a decrease compare to $-0.18 realized in previous quarter.


second quarter of 2021
Earnings Per Share Revenues
$ -0.21 $  10 Mill
$+0.11     $+2M     +29.41 %



Strongbridge Biopharma Plc's Revenue rose by 29.41 % in second quarter of 2021 (Jun 30 2021) year on year, to $10 million and advanced by 19.8 % sequentially.


Strongbridge Biopharma Plc is

More on SBBP's Income Statement



Strongbridge Biopharma Plc's in thesecond quarter of 2021 recorded net loss of $-13.241 million, an improvement compare to net loss of $-17.272 million in II. Quarter a year ago.

Sequentially net loss advanced

More on SBBP's Growth

Strongbridge Biopharma Plc Inventories
Inventories declined by -16.27 % to $1.10 million from II. Quarter a year ago, sequentially inventories rose by 9.33 %. In Jun 30 2021 company's net cash and cash equivalents decreased by $-10 million


Strongbridge Biopharma plc does not pay out common stock dividend.

In trailing twelve-month period Strongbridge Biopharma plc payed $ -0.50 cash per share, on a free-cash flow basis .

Book value fell by -21.15 % sequentially to $0.65 per share, -23.45% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.29 per share from $ 0.44.

Company issued 0.55 million shares or 0.81 % in Jun 30 2021.


More on SBBP's Dividends

 Market Capitalization (Millions) 136
 Shares Outstanding (Millions) 68
 Total Debt (Millions $) 18
 Revenue (TTM) (Millions $) 35
 Net Income (TTM) (Millions $) -40
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 156




Strongbridge Biopharma plc does not pay out common stock dividend.

In trailing twelve-month period Strongbridge Biopharma plc had negative $ -0.50 cash flow per share, on a free-cash flow basis .

Book value fell by -21.15 % sequentially to $0.65 per share, -23.45% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.29 per share from $ 0.44.

Company issued 0.55 million shares or 0.81 % in Jun 30 2021.


More on SBBP's Balance Sheets

 Market Capitalization (Millions) 136
 Shares Outstanding (Millions) 68
 Total Debt (Millions $) 18
 Revenue (TTM) (Millions $) 35
 Net Income (TTM) (Millions $) -40
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 156
   



Date modified: -0001-11-30T00:00:00+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com